Skip to content
Review

[Ten questions about cardiogenetics].

Nov 2026 · Giornale italiano di cardiologia · Vol 27 11, pp. 758-770 · 0 citations
Medicine

TL;DR

This review aims to provide clinicians with an updated and pragmatic guide to the use of genetic testing in inherited cardiovascular diseases, and addresses when genetic testing should be requested in cardiomyopathies and channelopathies, which genes should be tested across different conditions, and how genetic results should be interpreted according to the underlying disease.

Abstract

In recent years, cardiogenetics has become a key component in the management of cardiomyopathies and channelopathies, reshaping diagnostic, prognostic, and therapeutic strategies for conditions characterized by substantial clinical heterogeneity and variable arrhythmic risk. However, the use of genetic testing in clinical practice remains challenging and requires careful assessment of test appropriateness, gene panel selection, and result interpretation. In particular, the frequent identification of variants of uncertain significance highlights the need for an integrated approach combining genetic findings, clinical phenotype, family history, and disease-specific features. This review, organized around ten practical questions, aims to provide clinicians with an updated and pragmatic guide to the use of genetic testing in inherited cardiovascular diseases. The manuscript will address when genetic testing should be requested in cardiomyopathies and channelopathies, which genes should be tested across different conditions, and how genetic results should be interpreted according to the underlying disease. It will also discuss the diagnostic and prognostic value of genetic findings, their role in arrhythmic risk stratification and therapeutic decision-making, and the use of cascade genetic testing in family screening. Finally, disease-specific aspects of genetic counseling, ethical implications, and the importance of a multidisciplinary, patient-centered approach will be emphasized.

View source

Similar papers

Review Sep 2026

Genetic testing for dilated and arrhythmogenic cardiomyopathies - A primer for cardiologists.

Genetic testing for dilated and arrhythmogenic cardiomyopathies (DCM, ACM) is increasingly important as it can refine diagnosis, inform risk stratification, and enable cascade screening. However, its clinical application remains challenging due to variable penetrance, phenotypic overlap, and marked genetic heterogeneit...

John C. Dillon, Sonali Arora, D. Kalra · 0 citations
Review Open access Oct 2026

Genetic Testing in Pediatric Cardiomyopathies: Diagnostic Yield, Variants of Uncertain Significance and Implications for Genetic Counseling

Current evidence from test selection to genetic counseling, management of relatives when only a variant of uncertain significance is identified, surveillance of genotype-positive, phenotype-negative relatives, psychosocial impact and shared responsibility for recontact after reclassification are summarized.

Iuliana Maria Zaharia, S. A. Rițiu, Norbert Wellmann et al. · 0 citations
Review Open access

Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders

Hereditary arrhythmogenic diseases represent a significant group of genetically based heart rhythm disorders that can lead to serious health consequences. Genetic diagnostics are crucial for identifying the underlying genetic variants responsible for these conditions. However, variants of uncertain significance (VUS) a...

Sarah Martin · 0 citations
Review Open access Oct 2026

Clinical and Prognostic Spectrum of Non-Dilated Left Ventricular Cardiomyopathy: The Role of Genetic Status

NDLVC management requires a paradigm shift towards a multi-parametric, genotype-directed framework, where cardiac magnetic resonance tissue characterisation and personalized risk scores are essential to optimize sudden cardiac death prevention.

C. Castelli, R. Rossini, A. Maffè et al. · 0 citations
Open access Oct 2026

10 tips to integrate genetic testing into nephrology practice

A substantial subset of chronic kidney disease has an underlying monogenic cause, both in children and adults. Modern sequencing technologies provide the means for broad genetic testing. Approaches to therapy and patient care become increasingly aetiology-based. Thus, unravelling the genetic cause is getting clinical...

Carsten Bergmann, Ines Schmidts, N. Bachmann · 0 citations
Open access Oct 2026

AI foundation model for pathogenic gene variant prediction in dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is a common heritable cardiomyopathy with substantial clinical and genetic heterogeneity (≈1 in 200). Determining whether a patient carries a likely pathogenic/pathogenic (LP/P) variant is clinically important since genotype status is associated with differences in disease course and...

F. El Kayouhi, L. Arts, F. Raijmakers et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.